Type

Range

Units

Status

Start Date

End Date

Financing

Study Design

Brief description/objective

The primary objective is to investigate the glycaemic control in adult
patients with type 2 diabetes (T2D) who have not previously been
treated with injectable glucose-lowering medication and who initiate
treatment with oral semaglutide according to local clinical practice.

The secondary objective is to investigate mean change in body
weight in adult patients with T2D who have not previously been
treated with injectable glucose-lowering medication and who initiate
treatment with oral semaglutide according to local clinical practice.